Injective drops 7.08% as sellers control trading near $5.25
Injective (INJ) is trading at $5.25, having fallen 7.08% over the past day. The asset currently sits below its key short- and medium-term moving averages, with long-term support still intact.
Highlights
- INJ/USD faces sustained bearish momentum, with price trading below key short- and medium-term moving averages.
- Oversold conditions on multiple technical indicators point to stretched downside, yet ongoing selling pressure dominates intraday trades.
- Near-term price is expected to fluctuate between $4.25 and $5.65, with a strong downside bias unless $5.55 resistance is reclaimed.
Bearish momentum intensifies as resistance holds on hourly chart
On the H1 timeframe, INJ/USD trades below the MA-20 at $5.51 and MA-50 at $5.59, but remains above the MA-200 at $4.21. The Ichimoku Kijun level at $5.55 acts as immediate resistance. Momentum indicators show a firmly negative outlook: MACD signals Sell, ADX is Neutral, and RSI reads 32.39. Both Stoch RSI and CCI are in oversold territory, while BBP points to seller dominance intraday. The Awesome Oscillator also supports this negative momentum profile.
Downside risk persists as consolidation expected within support band
Over the next 2–3 sessions, the expected volatility band for INJ/USD is $4.25 to $5.65. The likelihood of an upward breakout remains very low, with significant risk of further downside prevailing. Baseline expectation is for consolidation within this corridor, while a bullish scenario would require a sustained push above the $5.55 resistance. If the $4.25 support is lost, further declines could accelerate.
Earlier, analysts noted that Injective demonstrated bullish technical momentum and resilient network growth, supporting a positive outlook. However, the current shift to clearly negative momentum and a break below key moving averages marks a notable change, with traders now advised to monitor $4.25 as critical support amid heightened downside risk.
Latest Injective News
- Forex
- Crypto